12-51913187-G-T
Variant summary
Our verdict is Pathogenic. Variant got 23 ACMG points: 23P and 0B. PS1PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000020.3(ACVRL1):c.150G>T(p.Trp50Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000138 in 1,444,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W50R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000020.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 23 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACVRL1 | NM_000020.3 | c.150G>T | p.Trp50Cys | missense_variant | 3/10 | ENST00000388922.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACVRL1 | ENST00000388922.9 | c.150G>T | p.Trp50Cys | missense_variant | 3/10 | 1 | NM_000020.3 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1444186Hom.: 0 Cov.: 32 AF XY: 0.00000139 AC XY: 1AN XY: 716940
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Telangiectasia, hereditary hemorrhagic, type 2 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 1997 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 27, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects ACVRL1 function (PMID: 10187774, 14684682). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACVRL1 protein function. ClinVar contains an entry for this variant (Variation ID: 8246). This missense change has been observed in individuals with hereditary hemorrhagic telangiectasia (PMID: 9245985, 12843319; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tryptophan, which is neutral and slightly polar, with cysteine, which is neutral and slightly polar, at codon 50 of the ACVRL1 protein (p.Trp50Cys). - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 02, 2023 | Segregates with disease in affected individuals from a single family in the published literature (Abdalla et al., 2003); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies demonstrate mis-localization and impaired protein activity (Lux et al., 1999; Harrison et al., 2003); This variant is associated with the following publications: (PMID: 16611099, 22028876, 9245985, 10187774, 14684682, 12843319, 10694922, 10767348, 17576210, 22718755, 15266205) - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2022 | The p.W50C pathogenic mutation (also known as c.150G>T), located in coding exon 2 of the ACVRL1 gene, results from a G to T substitution at nucleotide position 150. The tryptophan at codon 50 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been reported in individuals with a clinical diagnosis of hereditary hemorrhagic telangiectasia (HHT) (Berg JN et al. Am J Hum Genet, 1997 Jul;61:60-7; Abdalla SA et al. J Med Genet, 2003 Jul;40:494-502). In vitro studies showed that this alteration results in low signaling activity probably due abnormal cellular localization (Lux A et al. J Biol Chem, 1999 Apr;274:9984-92; Harrison RE et al. J Med Genet, 2003 Dec;40:865-71). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is predicted to be deleterious by BayesDel in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at